Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
5.74
+0.33 (6.10%)
At close: Sep 18, 2025, 4:00 PM EDT
5.61
-0.13 (-2.26%)
After-hours: Sep 18, 2025, 7:17 PM EDT
Coya Therapeutics Employees
Coya Therapeutics had 8 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$52,932
Profits / Employee
-$2,542,366
Market Cap
96.00M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8 | 0 | - |
Dec 31, 2023 | 8 | 2 | 33.33% |
Dec 31, 2022 | 6 | 0 | - |
Dec 31, 2021 | 6 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
COYA News
- 2 days ago - Coya Therapeutics' COYA 303 Shows Promising Central Nervous System (CNS) Anti-inflammatory Effects and Systemic Regulatory T Cell (Treg) Enhancing Effects in a Preclinical Animal Inflammation Model - PRNewsWire
- 14 days ago - Coya Therapeutics' COYA 302 ALS Trial Accepted by NEALS as a NEALS-Affiliated Trial - PRNewsWire
- 15 days ago - PRISM MarketView Features Exclusive Q&A with Coya Therapeutics CEO Arun Swaminathan on Targeting Neurodegenerative Diseases Through Treg Therapies - GlobeNewsWire
- 15 days ago - Coya Therapeutics to Participate at Upcoming September Investor Conferences - PRNewsWire
- 24 days ago - Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) - PRNewsWire
- 5 weeks ago - Coya Therapeutics Reports Second Quarter Financial Results and Provides a Corporate Update - PRNewsWire
- 2 months ago - Coya Therapeutics Announces Publication of Scientific Research Linking Inflammation and Oxidative Stress to the Progression of Parkinson's Disease - Business Wire
- 2 months ago - Coya Therapeutics to Participate in the BTIG Virtual Biotechnology Conference July 29 – 30, 2025 - Business Wire